Source: Eur Respir Monogr 2014; 65: 116-124
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Rune Grønseth, Sven-Arne Jansson. The economic burden of respiratory diseases: COPD and asthma. Eur Respir Monogr 2014; 65: 116-124

Member's Comments

No comment yet.

Related content which might interest you: The global burden of chronic respiratory diseases Source: ISSN=ISSN 1810-6838, ISBN=, page=20 Year: 2006 The occupational burden of respiratory diseases Source: Annual Congress 2009 - Best of ERS Year: 2009 Epidemiology of COPD: social burden and trends for the future Source: Annual Congress 2006 - PG13 - COPD: from aetiology to management Year: 2006 GBD 2017 estimates on asthma, COPD and other: challenges to measure respiratory disease worldwide Source: International Congress 2019 – The Global Burden of Disease, Global Alliance for Chronic Diseases and Forum of International Respiratory Societies and other international initiatives Year: 2019 Interpreting thresholds for a clinically significant change in health status in asthma and COPD Source: Eur Respir J 2002; 19: 398-404 Year: 2002 COPD and asthma: the main noncommunicable diseases that should be tackled? Source: International Congress 2018 – New challenges in tackling known diseases with the 10 ERS Principles for Lung Health Year: 2018 Socioeconomic risk factors for COPD and respiratory symptoms in a general population Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Prevalence and co-morbidity of asthma, chronic bronchitis and emphysema: a pan-European estimation Source: Eur Respir J 2006; 28: Suppl. 50, 449s Year: 2006 The threat in chronic lung diseases: acute exacerbations Source: Eur Respir Rev, 26 (145) 170075; 10.1183/16000617.0075-2017 Year: 2017 The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases Source: International Congress 2014 – Markers Year: 2014 Clinical characteristics and health burden of patients with chronic obstructive pulmonary disease exacerbation Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015 Prioritised research agenda for prevention and control of chronic respiratory diseases Source: Eur Respir J 2010; 36: 995-1001 Year: 2010 The impact of airway infection on cardiovascular risk during COPD exacerbations Source: Annual Congress 2012 - Acute exacerbation in COPD Year: 2012 Christmas as a risk factor for exacerbations of COPD, adult asthma and respiratory infections Source: Annual Congress 2007 - Environmental and clinical aspects of COPD Year: 2007 The occupational burden of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 462-469 Year: 2003 Household pollution and obstructive diseases: asthma and COPD Source: Virtual Congress 2020 – Spanish/Portuguese programme 2020: Part II Year: 2020 Reducing the risk of COPD exacerbations as results of personalized therapy of co-morbidity with upper respiratory tract diseases Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Area-level socio-economic status and health status among adults with asthma and rhinitis Source: Eur Respir J 2006; 27: 85-94 Year: 2006 Impact of age-related comorbidities on the risk of COPD exacerbations in subjects with severe airflow limitation: A pan-European study Source: Annual Congress 2013 –COPD mechanisms Year: 2013